SPG
61
8
F
46
4
HCP
74
16
TRV
45
2
AMGN
57
11
CFG
36
4
DGX
33
2
AAP
26
2
SRCL
54
-13
GPC
38
3
SBUX
33
-2
HOG
33
2
NTAP
64
-2
NOV
40
3
AMAT
55
-5
MDT
42
-2
MSFT
65
-2
PNC
45
4
PX
62
14
FIS
46
-2
SPG
61
8
F
46
4
HCP
74
16
TRV
45
2
AMGN
57
11
CFG
36
4
DGX
33
2
AAP
26
2
SRCL
54
-13
GPC
38
3
SBUX
33
-2
HOG
33
2
NTAP
64
-2
NOV
40
3
AMAT
55
-5
MDT
42
-2
MSFT
65
-2
PNC
45
4
PX
62
14
FIS
46
-2
Financhill
Back

Cytokinetics Stock Predictions

Elon's New AI Device is About to Shock the World

Click here to see the details because a lot of people could get rich from this new invention.
Buy
52

CYTK
Cytokinetics

Last Price:
52.86
Seasonality Move:
5.69%

7 Day Trial

ALL ACCESS PASS

$ 7

The Next Nvidia?

Go here now for this breaking story.

Cytokinetics Stock Forecast

  • Over the next 52 weeks, Cytokinetics has on average historically risen by 10.1% based on the past 20 years of stock performance.
  • Cytokinetics has risen higher in 10 of those 20 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
  • Is Cytokinetics Stock Undervalued?
    The current Cytokinetics [CYTK] share price is $53.85. The Score for CYTK is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
  • CYTK is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.

Will Cytokinetics Stock Go Up Next Year?

  • Over the next 52 weeks, Cytokinetics has on average historically risen by 10.1% based on the past 20 years of stock performance.

Cytokinetics Stock Rating

Buy
52
Cytokinetics (CYTK) is a Buy

Is Cytokinetics overpriced?

  • Cytokinetics has risen higher in 10 of those 20 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%

Cytokinetics Stock Price History

Is CYTK stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CYTK is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
cytokinetics.com

52-Week Data

52-Week High:
110.25
52-Week Low:
25.98

Prediction Charts

Market Cap:
5.65B
Price in USD:
53.85
Volume:
909.98K
Beta:
1.45

Technical Analysis

SMA50:
58.73
SMA100:
65.68
SMA200:
55.73
52-Wk Change:
52.9%

Stock Predictions

  • Is Cytokinetics stock public?
    Yes, Cytokinetics is a publicly traded company.
  • What is the Cytokinetics stock quote today?
    The Cytokinetics stock price is 53.85 USD today.
  • How to buy Cytokinetics stock online?
    You can buy Cytokinetics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Jun-4 49.16 48.41 49.38 47.82
Jun-5 48.68 54.58 55.00 47.02
Jun-6 54.25 52.28 54.75 52.00
Jun-7 52.10 52.79 52.94 50.87
Jun-10 52.07 54.16 54.45 51.51
Jun-11 53.52 53.29 54.04 52.56
Jun-12 54.50 54.03 54.83 53.56
Jun-13 54.02 52.73 54.41 52.67
Jun-14 52.23 53.93 54.35 51.87
Jun-17 53.07 52.78 53.77 52.08
Jun-18 52.71 51.94 53.44 51.57
Jun-20 51.81 51.81 52.88 51.50
Jun-21 52.21 53.55 53.80 51.62
Jun-24 53.75 53.85 54.57 53.01

Cytokinetics Earnings

Cytokinetics Earnings Report: Per Share Cytokinetics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Cytokinetics Forecast Revenue Growth

Cytokinetics Stock Analysis: Historical quarterly revenues per share for Cytokinetics and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.33 per share, an increase next quarter of $0.02 per share, an increase this year of $0.56 per share, and an increase next year of $0.08 per share.

* Cytokinetics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.